⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001856069

Doyle Ramona

Reports to the SEC for 1 company · SALT LAKE CITY, UT

Transactions

16

Companies

1

Filings

7

CIK

0001856069

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-16	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−832 sh	$5.67	−$4,717.44	121,110
2022-03-31	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,072 sh	—	—	669,356
2022-03-31	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,072 sh	$2.48	+$22.5K	121,942
2022-02-28	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15.6K sh	$2.48	+$38.8K	112,870
2022-02-28	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−15.6K sh	—	—	678,428
2022-02-04	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−981 sh	$11.40	−$11.2K	97,245
2022-02-04	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+77K sh	—	—	76,998
2022-02-04	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,784 sh	—	—	4,784
2022-02-04	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Medical Officer	AAward	+38.5K sh	—	—	95,834
2022-02-04	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Medical Officer	AAward	+2,392 sh	—	—	98,226
2022-01-31	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−15.6K sh	—	—	694,053
2022-01-31	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15.6K sh	$2.48	+$38.8K	57,335
2022-01-03	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+40.3K sh	$2.47	+$99.6K	40,322
2022-01-03	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−40.3K sh	—	—	709,678
2021-04-20	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)C Conversion	Chief Medical Officer	CConversion	−750K sh	—	—	0
2021-04-20	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)C Conversion	Chief Medical Officer	CConversion	+750K sh	—	—	750,000

Recent filings

7

Accepted (ET)
May 184
Doyle Ramona0001209191-22-030255
SEC(opens sec.gov)
Apr 44
Doyle Ramona0001209191-22-022310
SEC(opens sec.gov)
Mar 14
Doyle Ramona0001209191-22-014405
SEC(opens sec.gov)
Feb 84
Doyle Ramona0001209191-22-007915
SEC(opens sec.gov)
Feb 24
Doyle Ramona0001209191-22-006598
SEC(opens sec.gov)
Jan 54
Doyle Ramona0001209191-22-002062
SEC(opens sec.gov)
Apr 224
Doyle Ramona0001209191-21-028028
SEC(opens sec.gov)

Companies

1

RECURSION PHARMACEUTICALS, INC.Chief Medical OfficerRXRX

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101